Characteristics, management and outcomes of atypical haemolytic uraemic syndrome in kidney transplant patients: a retrospective national study

Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors

(2019) Alice Le Clech et al.   KIDNEY INTERNATIONAL

Outcomes of Kidney Transplant Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab: A Systematic Review and Meta-Analysis

(2019) Maria L. Gonzalez Suarez et al.   Journal of Clinical Medicine

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome

(2019) Julien Zuber et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Renal Transplantation in Patients With Atypical Hemolytic Uremic Syndrome: A Single Center Experience

(2019) Nadir Alpay et al.   TRANSPLANTATION PROCEEDINGS

A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome

(2018) Ana Huerta et al.   KIDNEY INTERNATIONAL

De novo thrombotic microangiopathy after kidney transplantation

(2018) Neetika Garg et al.   Transplantation Reviews

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

(2017) Timothy H.J. Goodship et al.   KIDNEY INTERNATIONAL

Eculizumab in secondary atypical haemolytic uraemic syndrome

(2017) Teresa Cavero et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis

(2017) Christophe M. Legendre et al.   TRANSPLANT INTERNATIONAL

Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial

(2016) Fadi Fakhouri et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation

(2016) Fadi Fakhouri et al.   Clinical Journal of the American Society of Nephrology

Actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento. Documento de consenso

(2015) Josep M. Campistol et al.   NEFROLOGIA

Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature

(2015) Anuja Java et al.   TRANSPLANT INTERNATIONAL

Syndromes of Thrombotic Microangiopathy

(2014) James N. George et al.   NEW ENGLAND JOURNAL OF MEDICINE

Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation

(2013) Marina Noris et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation

(2012) J. Zuber et al.   AMERICAN JOURNAL OF TRANSPLANTATION

New insights into postrenal transplant hemolytic uremic syndrome

(2010) Julien Zuber et al.   Nature Reviews Nephrology

Atypical Hemolytic–Uremic Syndrome

(2009) Marina Noris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Complement and Renal Transplantation: From Donor to Recipient

(2008) Jeffrey Damman et al.   TRANSPLANTATION